Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

AMGA Calls for Enhanced Care Coordination in its Comments on Proposed CY 2017 Physician Fee Schedule and Hospital Outpatient Prospective Payment System Proposed Rules

Alexandria, VA –AMGA today submitted written comments on the Centers for Medicare & Medicaid Services (CMS) CY 2017 Physician Fee Schedule and the CY 2017 Hospital Outpatient Prospective Payment System proposed rules.

Pediatricians told not to use nasal flu vaccine this year

Ahead of flu season, the American Academy of Pediatrics has released its recommendations for using vaccines and antiviral medications for flu prevention, and nasal spray vaccines aren’t part of its plan.

Fresenius sued by Kentucky over marketing of kidney dialysis product

The nation’s largest provider of kidney dialysis and renal care products is being sued by the state of Kentucky, alleging deceptive marketing of its GranuFlo blood screening product.

Interest groups not satisfied with proposed risk adjustment changes

CMS’s proposals to change risk adjustment calculations for exchange plans for 2018 would come too late, according to America’s Health Insurance Plans (AHIP) and Consumers for Health Options, Insurance Coverage in Exchanges in States (CHOICES).

‘Simple choice plans’ will be available for 2017 exchange customers

Insurance coverage with standardized deductibles, out-of-pocket spending limits and co-pays will be available during the next open enrollment period for health insurance marketplaces, according to Kaiser Health News.

CMS has plan to end dual enrollment in exchange plans and Medicare

CMS has told members of Congress it will contact customers who are enrolled in both Medicare and a subsidized insurance plan purchased through the Affordable Care Act’s exchanges, and tell them to leave their exchange plan immediately.

Why lawmakers keep making ‘compassionate use’ requests for controversial doctor

Requesting access to experimental, unapproved treatments from the FDA can sometimes save a patient’s life when no other treatment has worked. But as STAT’s Sheila Kaplan writes, there is a dark side to “compassionate use.”

Thumbnail

NIH Director Collins preaches optimism and big ideas to medical researchers in Chicago

National Institutes of Health Director Francis Collins, MD, PhD, told a crowd of medical researchers in Chicago he has a “sense of optimism” about the ability to offer more grants through the agency, while encouraging them not to shy away from bold projects.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.